Login
$MENS
$1.77 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Current Assets
Cash
Restricted cash
Prepayments and other current assets
Loan receivable from shareholder
Total current assets
Property and equipment, net
Operating right-of-use assets
Restricted asset
Other non-current assets
Total non-current assets
TOTAL ASSETS
Current liabilities
Short-term bank loans
Notes and accounts payable
Accrued expenses
Accrued expenses due to related parties
Current portion of long-term bank loans
Operating lease liabilities due to related parties-current
Accrued liabilities - guarantee obligation
Other current liabilities
Other current liabilities due to related parties
Total current liabilities
Long-term loan from related parties
Long-term loan from third parties
Long-term bank loans, net of current portion
Operating lease liabilities due to related parties – non-current
Other non-current liabilities
Other non-current liabilities due to related parties
Total non-current liabilities
TOTAL LIABILITIES
Shareholders’ deficit
Ordinary shares, $0.00001 par value; 5,000,000 thousand shares authorized; 73,361 thousand and 76,028 thousand shares issued and outstanding as of December 31, 2024 and 2025, respectively
Additional paid-in capital
Treasury shares, 1,794 thousand shares as of December 31, 2024 and 2025, respectively
Accumulated deficit
Accumulated other comprehensive income
Total shareholders’ deficit
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support